Stephen Stefani

688 total citations · 1 hit paper
29 papers, 321 citations indexed

About

Stephen Stefani is a scholar working on Economics and Econometrics, Sociology and Political Science and Oncology. According to data from OpenAlex, Stephen Stefani has authored 29 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 7 papers in Sociology and Political Science and 7 papers in Oncology. Recurrent topics in Stephen Stefani's work include Public Health in Brazil (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Stephen Stefani is often cited by papers focused on Public Health in Brazil (7 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Economic and Financial Impacts of Cancer (6 papers). Stephen Stefani collaborates with scholars based in Brazil, United States and Argentina. Stephen Stefani's co-authors include Jan Geißler, Lotte Steuten, Nicola Normanno, Philippe Aftimos, Joaquı́n Mateo, Don Husereau, D. M. Davies, Emile E. Voest, David M. Thomas and Elena Garralda and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen Stefani

26 papers receiving 316 citations

Hit Papers

Delivering precision oncology to patients with cancer 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Delivering precision oncology to patients with cancer
    2022 197 citations Joaquı́n Mateo, Lotte Steuten et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Stefani Brazil 7 108 86 78 77 42 29 321
John Marquart United States 5 105 1.0× 93 1.1× 73 0.9× 63 0.8× 41 1.0× 11 285
Séverine Sarp Switzerland 9 109 1.0× 196 2.3× 119 1.5× 76 1.0× 21 0.5× 18 398
Paula Cabrera‐Galeana Mexico 10 155 1.4× 138 1.6× 75 1.0× 50 0.6× 17 0.4× 34 295
Débora S. Bruno United States 12 82 0.8× 215 2.5× 51 0.7× 128 1.7× 25 0.6× 45 352
R. Wolters Germany 10 187 1.7× 192 2.2× 46 0.6× 69 0.9× 27 0.6× 14 330
Ellen V. Sigal United States 10 100 0.9× 103 1.2× 81 1.0× 57 0.7× 137 3.3× 23 405
A.L. Vataire France 13 158 1.5× 157 1.8× 68 0.9× 170 2.2× 114 2.7× 34 478
André Mattar Brazil 9 83 0.8× 141 1.6× 49 0.6× 40 0.5× 24 0.6× 46 292
Robin Schaffar Switzerland 10 64 0.6× 196 2.3× 33 0.4× 126 1.6× 34 0.8× 19 338
Ramy Saleh Canada 13 94 0.9× 187 2.2× 59 0.8× 133 1.7× 24 0.6× 57 397

Countries citing papers authored by Stephen Stefani

Since Specialization
Citations

This map shows the geographic impact of Stephen Stefani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Stefani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Stefani more than expected).

Fields of papers citing papers by Stephen Stefani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Stefani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Stefani. The network helps show where Stephen Stefani may publish in the future.

Co-authorship network of co-authors of Stephen Stefani

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Stefani. A scholar is included among the top collaborators of Stephen Stefani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Stefani. Stephen Stefani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Stefani, Stephen, et al.. (2023). Evolution of cancer treatment costs in the last 36 months in a self-funded health care in Brazil.. Journal of Clinical Oncology. 41(16_suppl). e18838–e18838. 1 indexed citations
3.
Mateo, Joaquı́n, Lotte Steuten, Philippe Aftimos, et al.. (2022). Delivering precision oncology to patients with cancer. Nature Medicine. 28(4). 658–665. 197 indexed citations breakdown →
4.
Peixoto, Renata D’Alpino, et al.. (2022). BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities. Cureus. 14(11). e31972–e31972. 1 indexed citations
5.
Stefani, Stephen, et al.. (2019). MA24.10 Estimation of Deaths Due to Lack of Access to Immunotherapy for Brazilian Patients Diagnosed with Advanced NSCLC Without Any Driver Mutation. Journal of Thoracic Oncology. 14(10). S349–S349. 2 indexed citations
6.
Coudry, Renata A., Carlos Gil Ferreira, Stephen Stefani, et al.. (2019). Increasing access to next-generation sequencing in oncology for Brazil. The Lancet Oncology. 20(1). 20–23. 5 indexed citations
7.
8.
Ferreira, Carlos Gil, et al.. (2018). The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy. Current Drug Targets. 20(1). 81–86. 5 indexed citations
9.
Ferreira, Carlos Gil, et al.. (2017). Increasing access to immuno-oncology therapies in Brazil. Journal of Cancer Policy. 16. 1–5. 6 indexed citations
10.
Ferreira, Carlos Gil, Maria Isabel Achatz, Patrícia Ashton‐Prolla, et al.. (2016). Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing. The Lancet Oncology. 17(8). e363–e370. 11 indexed citations
11.
Stefani, Stephen, et al.. (2016). Número necessário a tratar (NNT) e custo por evento evitado (COPE) de enzalutamida e acetato de abiraterona para o tratamento de câncer de próstata resistente à castração que falharam a terapia de privação de androgênio. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 8(2). 141–148. 1 indexed citations
12.
Szende, Ágota, Jason C. Allaire, Marco Petti, et al.. (2016). Budgetary impact of lipegfilgrastim to the Brazilian public healthcare system.. Journal of Clinical Oncology. 34(15_suppl). e14072–e14072. 1 indexed citations
13.
Stefani, Stephen, et al.. (2012). PCN61 Melody Brazil – Resource Use and Associated Costs With Metastatic Melanoma in Brazilian Health Care System. Value in Health. 15(7). A419–A420. 1 indexed citations
14.
15.
Araújo, Gabriela Tannus Branco de, et al.. (2011). Is Equity of Access to Health Care Achievable in Latin America?. Value in Health. 14(5). S8–S12. 13 indexed citations
16.
Carraro, Silvia, et al.. (2009). [Measurement of exhaled nitric oxide].. PubMed. 61(1). 99–102. 1 indexed citations
17.
Stefani, Stephen, et al.. (2008). Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective. Journal of Medical Economics. 11(3). 383–396. 9 indexed citations
18.
Tefilli, Marcos V., Stephen Stefani, & Mirandolino Batista Mariano. (2003). Urethral metastasis of lung carcinoma with germinative cell features. International braz j urol. 29(5). 431–433. 5 indexed citations
19.
Stefani, Stephen, et al.. (2001). Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.. PubMed. 68(6). 389–95. 26 indexed citations
20.
Menna‐Barreto, Sérgio Saldanha, et al.. (1997). Tromboembolia pulmonar em necropsias no Hospital de Clínicas de Porto Alegre, 1985-1995. Jornal Brasileiro de Pneumologia. 23(3). 131–136. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Marquart Breakdown of academic impact, for papers by Séverine Sarp Breakdown of academic impact, for papers by Paula Cabrera‐Galeana Breakdown of academic impact, for papers by Débora S. Bruno Breakdown of academic impact, for papers by R. Wolters Breakdown of academic impact, for papers by Ellen V. Sigal Breakdown of academic impact, for papers by A.L. Vataire Breakdown of academic impact, for papers by André Mattar Breakdown of academic impact, for papers by Robin Schaffar Breakdown of academic impact, for papers by Ramy Saleh
Rankless by CCL
2026